Physician profile
Mark Wainstein
NPI 1225033996
$4,779.82
in general payments reported to CMS, 2019-2025
30 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $226 · 2021: $505 · 2022: $2,400 · 2023: $426 · 2024: $348 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,928.52 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $534.18 | 2019-2023 | Aveed, Xiaflex, Edex |
| Intuitive Surgical, INC. | $416.43 | 2022 | |
| Abbvie INC. | $237.76 | 2019-2025 | Botox |
| Myovant Sciences INC. | $206.39 | 2021-2022 | |
| Astellas Pharma US INC | $173.49 | 2019-2024 | Xtandi, Myrbetriq |
| Myriad Genetic Laboratories, INC. | $149.31 | 2021-2024 | Prolaris |
| Bluewind Medical | $146.56 | 2025 | Revi |
| Medtronic USA, INC. | $121.82 | 2019 | |
| Laborie Medical Technologies Corp. | $119.01 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology, Eclipse |
| Conmed Corporation | $104.55 | 2022 | |
| Calyxo, INC. | $81.84 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $75.96 | 2021-2023 | Interstim |
| Teleflex LLC | $73.35 | 2022-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $63.37 | 2023-2025 | Orgovyx, Gemtesa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $43.39 | 2019-2021 | |
| Endo USA, INC. | $36.73 | 2024 | Xiaflex |
| Karl Storz Endoscopy-America | $28.11 | 2019 | |
| Olympus America INC. | $27.71 | 2024 | Itind System |
| Accord Healthcare, INC. | $24.50 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.21 | 2024 | |
| Allergan, INC. | $24.06 | 2022 | |
| Siemens Medical Solutions USA, INC. | $23.90 | 2019 | |
| Becton, Dickinson and Company | $22.84 | 2025 | Aptra |
| Dornier Medtech America, INC | $21.53 | 2020 | |
| Pfizer INC. | $20.40 | 2023 | |
| Urovant Sciences INC | $18.33 | 2022 | |
| Dentsply Ih Ab | $17.13 | 2025 | Lofric |
| Cook Medical LLC | $14.44 | 2024 | S~Curve |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wainstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.